C. P. Cannon,& P. T. O'Gara, Critical Pathways in Cardiovascular Medicine (Board Review Series) USMLE

Rapidshare or MiHD or zupload or sendspace or depositfiles


Critical Pathways in Cardiovascular Medicine (Board Review Series)

Rapidshare or MiHD or zupload or sendspace or depositfiles


Critical Pathways in Cardiovascular Medicine (Board Review Series)

C. P. Cannon,& P. T. O'Gara, Critical Pathways in Cardiovascular Medicine (Board Review Series) USMLE
Lippincott Williams & Wilkins | ISBN:0781794390 | 2nd edition (October 1, 2006) | 336 pages | CHM | 11.4 MB
Critical Pathways in Cardiovascular Medicine, Second Edition presents evidence-based, cost-effective critical pathways for diagnosis and management of cardiovascular disorders in the pre-hospital setting, emergency department, inpatient setting, and outpatient setting. All pathways in this edition have been updated to reflect the latest findings regarding best practices in all areas of cardiovascular care. Coverage includes new pathways for pre-hospital care, public access defibrillation for cardiac arrest, emergency department management of heart failure and atrial fibrillation, aortic aneurysm, hyperglycemia, peripheral artery disease and claudication, implantable cardioverter defibrillator treatment for ventricular tachycardia, and long-term management of diabetes and the metabolic syndrome.


Lippincott Williams & Wilkins | ISBN:0781794390 | 2nd edition (October 1, 2006) | 336 pages | CHM | 11.4 MB
Critical Pathways in Cardiovascular Medicine, Second Edition presents evidence-based, cost-effective critical pathways for diagnosis and management of cardiovascular disorders in the pre-hospital setting, emergency department, inpatient setting, and outpatient setting. All pathways in this edition have been updated to reflect the latest findings regarding best practices in all areas of cardiovascular care. Coverage includes new pathways for pre-hospital care, public access defibrillation for cardiac arrest, emergency department management of heart failure and atrial fibrillation, aortic aneurysm, hyperglycemia, peripheral artery disease and claudication, implantable cardioverter defibrillator treatment for ventricular tachycardia, and long-term management of diabetes and the metabolic syndrome.